Latest industry research report on Kidney cancer or renal cancer is one of the ten most frequently diagnosed cancers, found mainly in people aged 60 or above. According to the estimates of the American Cancer Society (ACS), 61,560 new kidney cancer cases and 14,080 deaths would occur in 2015. Due to the increasing prevalence with no cure of this deadly disease, till date, there is an imminent need for effective kidney cancer drugs.
The renal cancer drug therapy market has witnessed a dramatic change in its treatment paradigm over the last three decades. Although, there are a variety of treatment options available, innovators have now shifted their focus towards more targeted therapies and immunotherapies. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking.
Get Free Sample Report Of Kidney cancer or renal cancer Market @ http://www.marketresearchstore.com/report/world-kidneyrenal-cancer-drugs-market-opportunities-and-71727#RequestSample
Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boosting the growth of the market. Strong pipeline and fast-emerging treatments are expected to further boost the market during the analysis period. However, high cost of drugs, looming off-patents and uncertain reimbursement policies are some of the factors that are likely to restrain the market growth.
Winning a physicians confidence regarding the cost, efficacy and dosage would lead to a higher acceptance of drugs in the market. Additionally, immunotherapies would emerge as an opportunity for innovators in the kidney cancer drugs market. Furthermore, untapped geographies with a high undiagnosed patient base would offer lucrative opportunities for the innovators in future. However, overcoming the generic drugs competition would be a key challenge for the leading innovators.
Do Inquiry To Buy Report Of Kidney cancer or renal cancer Market @ http://www.marketresearchstore.com/report/world-kidneyrenal-cancer-drugs-market-opportunities-and-71727#InquiryForBuying
The market is expected to register substantial growth in the near future. This can be attributed to the various strategies adopted by the leading industry players. One of the key strategies adopted is collaboration agreement. Recently, Roche signed an agreement with Celldex Therapeutics, Inc. in order to evaluate the safety and efficacy of its immunotherapy drug, namely, MPDL3280A in combination with latters CD27 targeting investigational antibody, varlilumab for the treatment of renal cell carcinoma.
The Global Kidney Cancer Drugs Market segmentation is illustrated below:
By Therapy Type
- Targeted Therapy
- Approved drugs
- Pipeline drugs
- Rest of Europe
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
About Market research Store
Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading publishers and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442, USA
USA Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651